Latigo Biotherapeutics, Inc. (LTGO)
Nasdaq: LTGO · CIK 0002056611 · United States
Every official Latigo Biotherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open LTGO filings
Latigo Biotherapeutics, Inc. documents
- Latigo Biotherapeutics, Inc. 10-K 2026LTGO 10-K 2026: annual report for fiscal 2026
- Latigo Biotherapeutics, Inc. 10-K 2025LTGO 10-K 2025: annual report for fiscal 2025
- Latigo Biotherapeutics, Inc. 10-K 2024LTGO 10-K 2024: annual report for fiscal 2024
- Latigo Biotherapeutics, Inc. 10-K 2023LTGO 10-K 2023: annual report for fiscal 2023
- Latigo Biotherapeutics, Inc. 10-K 2022LTGO 10-K 2022: annual report for fiscal 2022
- Latigo Biotherapeutics, Inc. 10-Q 2026LTGO 10-Q 2026: quarterly report for fiscal 2026
- Latigo Biotherapeutics, Inc. 10-Q 2025LTGO 10-Q 2025: quarterly report for fiscal 2025
- Latigo Biotherapeutics, Inc. 10-Q 2024LTGO 10-Q 2024: quarterly report for fiscal 2024
- Latigo Biotherapeutics, Inc. 10-Q 2023LTGO 10-Q 2023: quarterly report for fiscal 2023
- Latigo Biotherapeutics, Inc. 10-Q 2022LTGO 10-Q 2022: quarterly report for fiscal 2022
- Latigo Biotherapeutics, Inc. 8-K 2026LTGO 8-K 2026: current report for fiscal 2026
- Latigo Biotherapeutics, Inc. 8-K 2025LTGO 8-K 2025: current report for fiscal 2025
- Latigo Biotherapeutics, Inc. 8-K 2024LTGO 8-K 2024: current report for fiscal 2024
- Latigo Biotherapeutics, Inc. 8-K 2023LTGO 8-K 2023: current report for fiscal 2023
- Latigo Biotherapeutics, Inc. 8-K 2022LTGO 8-K 2022: current report for fiscal 2022
- Latigo Biotherapeutics, Inc. DEF 14A 2026LTGO DEF 14A 2026: proxy statement for fiscal 2026
- Latigo Biotherapeutics, Inc. DEF 14A 2025LTGO DEF 14A 2025: proxy statement for fiscal 2025
- Latigo Biotherapeutics, Inc. DEF 14A 2024LTGO DEF 14A 2024: proxy statement for fiscal 2024
- Latigo Biotherapeutics, Inc. DEF 14A 2023LTGO DEF 14A 2023: proxy statement for fiscal 2023
- Latigo Biotherapeutics, Inc. DEF 14A 2022LTGO DEF 14A 2022: proxy statement for fiscal 2022
- Latigo Biotherapeutics, Inc. Form 4 2026LTGO Form 4 2026: insider trading filing for fiscal 2026
- Latigo Biotherapeutics, Inc. Form 4 2025LTGO Form 4 2025: insider trading filing for fiscal 2025
- Latigo Biotherapeutics, Inc. Form 4 2024LTGO Form 4 2024: insider trading filing for fiscal 2024
- Latigo Biotherapeutics, Inc. Form 4 2023LTGO Form 4 2023: insider trading filing for fiscal 2023
- Latigo Biotherapeutics, Inc. Form 4 2022LTGO Form 4 2022: insider trading filing for fiscal 2022
- Latigo Biotherapeutics, Inc. S-1 2026LTGO S-1 2026: registration statement for fiscal 2026
- Latigo Biotherapeutics, Inc. S-1 2025LTGO S-1 2025: registration statement for fiscal 2025
- Latigo Biotherapeutics, Inc. S-1 2024LTGO S-1 2024: registration statement for fiscal 2024
- Latigo Biotherapeutics, Inc. S-1 2023LTGO S-1 2023: registration statement for fiscal 2023
- Latigo Biotherapeutics, Inc. S-1 2022LTGO S-1 2022: registration statement for fiscal 2022
- Latigo Biotherapeutics, Inc. 13F 2026LTGO 13F 2026: institutional holdings for fiscal 2026
- Latigo Biotherapeutics, Inc. 13F 2025LTGO 13F 2025: institutional holdings for fiscal 2025
- Latigo Biotherapeutics, Inc. 13F 2024LTGO 13F 2024: institutional holdings for fiscal 2024
- Latigo Biotherapeutics, Inc. 13F 2023LTGO 13F 2023: institutional holdings for fiscal 2023
- Latigo Biotherapeutics, Inc. 13F 2022LTGO 13F 2022: institutional holdings for fiscal 2022
More companies